Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar;2(3):348-56.
doi: 10.1002/pro.5560020307.

Ribonuclease S-peptide as a carrier in fusion proteins

Affiliations

Ribonuclease S-peptide as a carrier in fusion proteins

J S Kim et al. Protein Sci. 1993 Mar.

Abstract

S-peptide (residues 1-20) and S-protein (residues 21-124) are the enzymatically inactive products of the limited digestion of ribonuclease A by subtilisin. S-peptide binds S-protein with high affinity to form ribonuclease S, which has full enzymatic activity. Recombinant DNA technology was used to produce a fusion protein having three parts: carrier, spacer, and target. The two carriers used were the first 15 residues of S-peptide (S15) and a mutant S15 in which Asp 14 had been changed to Asn (D14N S15). The spacer consisted of three proline residues and a four-residue sequence recognized by factor Xa protease. The target was beta-galactosidase. The interaction between the S-peptide portion of the fusion protein and immobilized S-protein allowed for affinity purification of the fusion protein under denaturing (S15 as carrier) or nondenaturing (D14N S15 as carrier) conditions. A sensitive method was developed to detect the fusion protein after sodium dodecyl sulfate-polyacrylamide gel electrophoresis by its ribonuclease activity following activation with S-protein. S-peptide has distinct advantages over existing carriers in fusion proteins in that it combines a small size (> or = 15 residues), a tunable affinity for ligand (Kd > or = 10(-9) M), and a high sensitivity of detection (> or = 10(-16) mol in a gel).

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Mol Biol. 1981 Jun 25;149(2):313-7 - PubMed
    1. FEBS Lett. 1968 Jul;1(1):29-31 - PubMed
    1. J Biol Chem. 1979 May 25;254(10):3788-96 - PubMed
    1. Methods Enzymol. 1987;153:461-81 - PubMed
    1. Eur J Biochem. 1975 Mar 3;52(1):65-76 - PubMed

Publication types

MeSH terms

LinkOut - more resources